China Pharma (CPHI)
Manufactures prescription pharmaceuticals for Chinese distributors across infection, CNS, cardiovascular, respiratory and digestive care.
$0.8410
Pre-market−0.00 (−0.47%)
At close$0.8450(−4.55%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions6 holders · as of Mar 31, 2026 | 0.06% | 25.8K shares | |
| Otherremainder | 99.94% | 43.00M shares |
43.02M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
6 holders · 25.8K shares · 2 new positions · 3 increased · 1 reduced · 1 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Citadel Advisors LLC | 12.9K | 0.03% | +12.9K | May 15, 2026 |
| Renaissance Technologies LLC | 11.4K | 0.03% | +100 | May 14, 2026 |
| Citigroup Inc | 996 | 0.00% | +996new | May 11, 2026 |
| UBS Group AG | 389 | 0.00% | −124 | May 5, 2026 |
| Efg International AG | 40 | 0.00% | 0 | May 15, 2026 |
| Danske Bank A/S | 1 | 0.00% | 0 | May 12, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.